sodium salicylate has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Callery, MP; Carrigan, RC; McDade, TP; Perugini, RA; Vittimberga, FJ | 1 |
1 other study(ies) available for sodium salicylate and Pancreatic Neoplasms
Article | Year |
---|---|
Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cell Nucleus; DNA Fragmentation; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Humans; I-kappa B Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Pancreatic Neoplasms; Phosphorylation; Sodium Salicylate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |